Development of a Bedside Pain Assessment Kit for Postherpetic Neuralgia (BSTK)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01166295|
Recruitment Status : Unknown
Verified August 2010 by Analgesic Solutions.
Recruitment status was: Recruiting
First Posted : July 21, 2010
Last Update Posted : August 5, 2010
Post herpetic neuralgia (PHN) is an undertreated condition. It is a type of neuropathic pain (NP), or pain caused by abnormal activity of sensory nerves. Its mechanisms are not fully understood, and medication trials for PHN pain and other types of NP are frequently unsuccessful.
There has been extensive investigation aimed at identifying and understanding the specific mechanisms of NP. While some of these tests are inexpensive and easy to perform at the bedside, many require expensive tools and highly equipped laboratory facilities. Further, there is no standard method for assessment of pain in NP patients.
The investigators aim to test a Bedside Sensory Testing Kit (assessment for Neuropathic Pain) on a small number of patients with PHN.
The purpose of the Kit is to identify mechanisms of pain. The goal of this research is to design a way to classify patients with PHN based on what mechanisms are causing their pain, since this may help predict the best medications for individual patients.
|Condition or disease|
|Neuralgia Herpes Zoster|
We hypothesize: (a) that a Bedside Sensory Testing Kit for PHN can be designed such that it works efficiently with Subjects and Investigators, is tolerated well by Subjects, and is statistically reliable between Investigators; (b) that the sensory testing kit can distinguish between PHN patients with different sensory qualities to their pain which may be caused by different underlying pain mechanisms.
The subjects will be patients with postherpetic neuralgia who voluntarily participate and meet eligibility criteria. The study participants will complete a brief questionnaire and undergo three rounds of the BSTK, performed by two study investigators. The items in the BSTK correspond to a series of sensory assessments, each of which are aimed to contribute to the characterization of individuals' PHN pain.
|Study Type :||Observational|
|Estimated Enrollment :||12 participants|
|Official Title:||Development of a Bedside Pain Assessment Kit for Postherpetic Neuralgia|
|Study Start Date :||July 2010|
|Estimated Primary Completion Date :||October 2010|
|Estimated Study Completion Date :||November 2010|
- Demonstrate usability of the BSTK. [ Time Frame: Subject Duration in the study is one (1) clinic visit ( approximatley 2-3 hours). We expect 10 weeks of open enrollment. Total study timeline is 4 months(1 month start up, 2 months enrollment, 1 month clean and analysis, 2 weeks final CSR. ]
Analysis of subject feedback regarding clarity of instructions, burden of study procedures, and overall experience.
Analysis of investigator observations regarding clinical feasibility, investigator burden, and overall experience.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01166295
|Contact: Nathaniel Katz, MD, MS||781.444.9605 ext email@example.com|
|Contact: Eric Osgood, MD||781.444.9605 ext firstname.lastname@example.org|
|United States, Massachusetts|
|Natick, Massachusetts, United States, 01760|
|Contact: Eric Osgood, MD 781-444-9605 ext 128 email@example.com|
|Principal Investigator: Nathaniel Katz, MD,MS|
|Sub-Investigator: Eric Osgood, MD|
|Principal Investigator:||Nathaniel Katz, MD, MS||Analgesic Solutions|